These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7922711)

  • 1. Do we need a "stopping rule" for breast cancer?
    Hudis CA
    Cancer Invest; 1994; 12(5):543-4. PubMed ID: 7922711
    [No Abstract]   [Full Text] [Related]  

  • 2. A stopping rule for standard chemotherapy for metastatic breast cancer: lessons from a survey of Maryland medical oncologists.
    Benner SE; Fetting JH; Brenner MH
    Cancer Invest; 1994; 12(5):451-5. PubMed ID: 7922700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast cancer patients failing first-line, anthracycline-containing chemotherapy: is further therapy of benefit?
    Campora E; Gardin G; Gasco M; Rosso R; Santi L
    Anticancer Res; 1999; 19(4C):3429-32. PubMed ID: 10629630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of treatment options in advanced breast cancer in the UK.
    Brown RE; Hutton J; Burrell A
    Pharmacoeconomics; 2001; 19(11):1091-102. PubMed ID: 11735676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting the economic literature in oncology.
    Grusenmeyer PA; Wong YN
    J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone, 5-fluorouracil and levo-leucovorin as salvage treatment in advanced breast cancer patients.
    Mammoliti S; Merlini L; Caroti C; Gallo L
    Eur J Cancer; 1994; 30A(2):248-9. PubMed ID: 8155400
    [No Abstract]   [Full Text] [Related]  

  • 7. [A clinical study of reasonable doses of docetaxel salvage therapy for patients with metastatic breast cancer].
    Wu SK; Ma Y; Meng XY; Sun B; Wang T; Zhang SH; Jiang ZF; Song ST
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):764-9. PubMed ID: 23291071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of doublet versus single agent as salvage treatment for metastatic breast cancer pretreated with anthracyclines and taxanes: a systematic review and meta-analysis.
    Zhang T; Wang R; Liu Y; Huang J; Yang Z
    Curr Med Res Opin; 2016 Nov; 32(11):1883-1889. PubMed ID: 27489049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of carboplatin and etoposide as salvage treatment for patients with metastatic breast cancer.
    Ron IG; Vishne TH; Kraminsky N; Bar-Am A; Inbar MJ
    Am J Clin Oncol; 1999 Feb; 22(1):35-7. PubMed ID: 10025377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide in the treatment of breast cancer.
    Overmoyer BA
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):38-41. PubMed ID: 8677447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Utility of CPT-11 as salvage chemotherapy for progressive or recurrent breast cancer patients with multiple drug resistance].
    Fushimi K; Nakano S; Kumagai K; Yamamoto N
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1095-9. PubMed ID: 20567115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage chemotherapy with mitoxantrone and mitomycin with or without methotrexate in advanced breast cancer.
    Astone A; Cassano A; Fontana T; Noviello MR; Pozzo C; Barone C
    Anticancer Drugs; 1992 Oct; 3(5):471-3. PubMed ID: 1450440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An advanced metastatic breast cancer patient successfully treated with combination therapy including docetaxel, doxorubicin and cyclophosphamide (TAC) as salvage therapy].
    Sato Y; Takayama T; Sagawa T; Sato T; Okamoto K; Takahashi S; Abe S; Iyama S; Murase K; Kato J; Niitsu Y
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):471-3. PubMed ID: 18347397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer.
    Porkka K; Blomqvist C; Rissanen P; Elomaa I; Pyrhönen S
    J Clin Oncol; 1994 Aug; 12(8):1639-47. PubMed ID: 8040676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined mitoxantrone therapy for heavily pretreated metastatic breast cancer].
    Yokoe T; Iino Y; Aoyagi H; Maemura M; Sugamata N; Takai Y; Horiguchi J; Ishida T; Morishita Y
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):169-71. PubMed ID: 8422183
    [No Abstract]   [Full Text] [Related]  

  • 16. Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
    Eichbaum MH; Schuetz F; Khbeis T; Lauschner I; Foerster F; Sohn C; Schneeweiss A
    Anticancer Drugs; 2007 Sep; 18(8):963-8. PubMed ID: 17667603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C in patients with gynecological malignancies.
    Kahmann L; Beyer U; Mehlhorn G; Thiel FC; Strnad V; Fasching PA; Lux MP
    Onkologie; 2010; 33(10):547-57. PubMed ID: 20926904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource-sparing and cost-effective strategies in current management of breast cancer.
    Munshi A
    J Cancer Res Ther; 2009; 5(2):116-20. PubMed ID: 19542668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage chemotherapy of breast cancer.
    Norton L
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):19-24. PubMed ID: 8091238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer.
    Jouve M; Dorval T; Mosseri V; Palangie T; Beuzeboc P; Garcia-Giralt E; Livartowski A; Scholl S; Pouillart P
    Eur J Cancer; 1993; 29A(9):1355. PubMed ID: 8343286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.